Literature DB >> 1252358

Prostaglandins and pruritus.

C R Lovell, P A Burton, E H Duncan, J L Burton.   

Abstract

We have found that pretreatment of human skin with prostaglandin E1 significantly lowers the threshold of human skin to itching evoked by both histamine and papain. Prostaglandins may thus potentiate pruritus in inflammatory skin disease, presumably by a non-specific effect on nerve-endings.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1252358     DOI： 10.1111/j.1365-2133.1976.tb04383.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


  7 in total

1.  Investigative studies of the dermatitis caused by the larva of the brown-tail moth, Euproctis chrysorrhoea l. (Lepidoptera, Lymantriidae). IV. Further characterization of skin reactive substances.

Authors:  M C de Jong; E Bleumink
Journal:  Arch Dermatol Res       Date:  1977-09-27       Impact factor: 3.017

2.  Effect of aspirin on pruritus.

Authors:  B M Daly; S Shuster
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-11

3.  The efficacy of histamine antagonists as antipruritics in experimentally induced pruritus.

Authors:  M G Davies; R Marks; R J Horton; F E Storari
Journal:  Arch Dermatol Res       Date:  1979-10       Impact factor: 3.017

4.  New perspectives on aspirin.

Authors:  G R Fryers
Journal:  Proc R Soc Med       Date:  1977

5.  Sensory responses of human skin to synthetic histamine analogues and histamine.

Authors:  M G Davies; M W Greaves
Journal:  Br J Clin Pharmacol       Date:  1980-05       Impact factor: 4.335

6.  Potentiation of histamine-induced itch and flare responses in human skin by the enkephalin analogue FK-33-824, beta-endorphin and morphine.

Authors:  B Fjellner; O Hägermark
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

Review 7.  New insights into the mechanisms of itch: are pain and itch controlled by distinct mechanisms?

Authors:  Tong Liu; Ru-Rong Ji
Journal:  Pflugers Arch       Date:  2013-05-01       Impact factor: 3.657
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.